{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:03:07Z","timestamp":1763643787637,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001209","name":"Knights Templar Eye Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ajoc.2023.101825","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T11:45:43Z","timestamp":1678275943000},"page":"101825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Identification of AFG3L2 dominant optic atrophy following reanalysis of clinical exome sequencing"],"prefix":"10.1016","volume":"30","author":[{"given":"Michael C.","family":"Brodsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rory J.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faizal Z.","family":"Asumda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline Q.R.","family":"Lopour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3154-4249","authenticated-orcid":false,"given":"Lisa A.","family":"Schimmenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric W.","family":"Klee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2023.101825_bib1","series-title":"Pediatric Neuro-Ophthalmology","first-page":"222","author":"Brodsky","year":"2016"},{"key":"10.1016\/j.ajoc.2023.101825_bib2","first-page":"135","article-title":"Hereditary infantile optic atrophy with dominant transmission (preliminary report)","volume":"3","author":"Kjer","year":"1956","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.ajoc.2023.101825_bib3","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1001\/archopht.1979.01020020248013","article-title":"Dominant optic atrophy: the clinical profile","volume":"97","author":"Kline","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2023.101825_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0161-6420(80)35247-0","article-title":"Autosomal dominant optic atrophy. A spectrum of disability","volume":"87","author":"Hoyt","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2023.101825_bib5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0002-9394(14)73589-5","article-title":"Visual prognosis in autosomal dominant optic atrophy","volume":"115","author":"Eliott","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2023.101825_bib6","first-page":"98","article-title":"Color vision in dominant optic atrophy","volume":"12","author":"Mantyjarvi","year":"1992","journal-title":"J Clin Neuro Ophthalmol"},{"key":"10.1016\/j.ajoc.2023.101825_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.116.3.351","article-title":"Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy","volume":"116","author":"Vortruba","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2023.101825_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/13816818509007860","article-title":"Probable autosomal dominant optic atrophy with hearing loss","volume":"5","author":"Mets","year":"1985","journal-title":"Ophthalmic Paediatr Genet"},{"key":"10.1016\/j.ajoc.2023.101825_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/13816818509007861","article-title":"Dominant optic atrophy with progressive hearing loss and chronic progressive external ophthalmoplegia (CPEO)","volume":"5","author":"Meire","year":"1985","journal-title":"Ophthalmic Paediatr Genet"},{"key":"10.1016\/j.ajoc.2023.101825_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/brain\/awm272","article-title":"Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness, and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance","volume":"131","author":"Hudson","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.ajoc.2023.101825_bib11","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/brain\/awq007","article-title":"Multi-system neurologic disease is common in patients with OPA mutations","volume":"133","author":"Yu-Wai-Man","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ajoc.2023.101825_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s002340050041","article-title":"MRI of the intraorbital optic nerve in patients with autosomal dominant optic atrophy","volume":"42","author":"Vortruba","year":"2000","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ajoc.2023.101825_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/79936","article-title":"Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy","volume":"26","author":"Delettre","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajoc.2023.101825_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/79944","article-title":"OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28","volume":"26","author":"Alexander","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajoc.2023.101825_bib15","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1074\/jbc.C200677200","article-title":"Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis","volume":"278","author":"Olichon","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajoc.2023.101825_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies","volume":"23","author":"Carelli","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajoc.2023.101825_bib17","first-page":"1715","article-title":"A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy","volume":"43","author":"Thisleton","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2023.101825_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.25723","article-title":"ATPase domain AFG3L2 mutations alter OPA1 processing and cause optic neuropathy","volume":"88","author":"Caporali","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajoc.2023.101825_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/ng.544","article-title":"Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28","volume":"42","author":"Di Bella","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajoc.2023.101825_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fgene.2015.00311","article-title":"A novel mutation of AFG3L2 might cause dominant optic atrophy in patients with mild intellectual disability","volume":"6","author":"Charif","year":"2015","journal-title":"Front Genet"},{"key":"10.1016\/j.ajoc.2023.101825_bib21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3892\/br.2017.987","article-title":"Non-syndromic isolated dominant optic atrophy caused by the p.R468C mutation in the AFG3 like matrix AAA peptidase subunit 2 gene","volume":"7","author":"Colavito","year":"2017","journal-title":"Biomed Rep"},{"key":"10.1016\/j.ajoc.2023.101825_bib22","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/humu.23658","article-title":"Concurrent AFG3L2 and SPG7 mutations associated with syndromic parkinsonism and optic atrophy with aberrant OPA1 processing and mitochondrial network fragmentation","volume":"39","author":"Magri","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ajoc.2023.101825_bib23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-2836(02)01000-8","article-title":"A novel two-step mechanism for removal of a mitochondrial signal sequence involves the mAAA complex and the putative rhomboid protease Pcp1","volume":"323","author":"Esser","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/j.ajoc.2023.101825_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cell.2005.08.003","article-title":"The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria","volume":"123","author":"Nolden","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ajoc.2023.101825_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/10409230701380452","article-title":"Protein degradation within mitochondria: versatile activities of AAA proteases and other peptidases","volume":"42","author":"Koppen","year":"2007","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"3","key":"10.1016\/j.ajoc.2023.101825_bib26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41436-020-01005-9","article-title":"Impact of integrated translational research on clinical exome sequencing","volume":"23","author":"Klee","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.ajoc.2023.101825_bib27","article-title":"The top 10 most frequently involved genes in hereditary optic neuropathies in 2186 probands","author":"Rocatcher","year":"2022","journal-title":"Brain"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993623000336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993623000336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:59:50Z","timestamp":1762527590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993623000336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":27,"alternative-id":["S2451993623000336"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2023.101825","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of AFG3L2 dominant optic atrophy following reanalysis of clinical exome sequencing","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2023.101825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101825"}}